Role of the AP-1 transcription factor FOSL1 in endothelial cell adhesion and migration

Cell Adhesion and Migration

Volumn 7, Issue 5, 2013, Pages 408-411

  Galvagni, Federico ^a   Orlandini, Maurizio ^a   Oliviero, Salvatore ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Hugef Torino Foundation   (Italy)

Author keywords

V 3 integrin; Angiogenesis; AP 1; Endothelial cell migration; FOSL1; FRA1; SP1; Transcription; uPA; uPAR

Indexed keywords

TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR FRA 1; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN RECEPTOR 3; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ANGIOGENESIS; CELL ADHESION; CELL MIGRATION; CELL SURFACE; ENDOTHELIUM CELL; HUMAN; REVIEW; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS; AP-1; ENDOTHELIAL CELL MIGRATION; FOSL1; FRA1; SP1; TRANSCRIPTION; UPA; UPAR; ΑVΒ3 INTEGRIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; INTEGRIN ALPHAVBETA3; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84891862518     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.25894     Document Type: Review

References (27)

1. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77; PMID:12810700; http://dx.doi.org/10. 1083/jcb.200302047
2. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339:269-80; PMID:19693543; http://dx.doi.org/10.1007/s00441-009-0834-6
3. Galvagni F, Pennacchini S, Salameh A, Rocchigiani M, Neri F, Orlandini M, et al. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ Res 2010; 106:1839-48; PMID:20431062; http://dx.doi.org/10.1161/CIRCRESAHA.109.206326
4. Brooks PC, Strömblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995; 96:1815-22; PMID:7560073; http://dx.doi.org/10.1172/JCI118227
5. Kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 2000; 156:1345-62; PMID:10751360; http://dx.doi.org/10. 1016/S0002-9440(10)65005-5
6. Valtola R, Salven P, Heikkilä P, Taipale J, Joensuu H, Rehn M, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999; 154:1381-90; PMID:10329591; http://dx.doi.org/10.1016/ S0002-9440(10)65392-8
7. Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 2000; 96:546-53; PMID:10887117
8. Galvagni F, Anselmi F, Salameh A, Orlandini M, Rocchigiani M, Oliviero S. Vascular endothelial growth factor receptor-3 activity is modulated by its association with caveolin-1 on endothelial membrane. Biochemistry 2007; 46:3998-4005; PMID:17348685; http://dx.doi.org/10.1021/bi061400n
9. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997; 139:257-64; PMID:9314544; http://dx.doi.org/10.1083/jcb.139.1.257
10. Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004; 279:4862-8; PMID:14610084; http://dx.doi.org/10.1074/jbc.M305190200
11. Charboneau A, East L, Mulholland N, Rohde M, Boudreau N. Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis 2005; 8:289-96; PMID:16328158; http://dx.doi.org/10.1007/s10456-005-9016-7
12. Hayashi H, Sano H, Seo S, Kume T. The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 2008; 283:23791-800; PMID:18579532; http://dx.doi.org/10.1074/jbc.M800190200
13. Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004; 10:974-81; PMID:15322537; http://dx.doi.org/10.1038/nm1094
14. Czyz M, Cierniewski CS. Selective Sp1 and Sp3 binding is crucial for activity of the integrin alphaV promoter in cultured endothelial cells. Eur J Biochem 1999; 265:638-44; PMID:10504395; http://dx.doi.org/10.1046/j.1432-1327. 1999.00754.x
15. Villa-Garcia M, Li L, Riely G, Bray PF. Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene. Blood 1994; 83:668-76; PMID:8298129
16. Galvagni F, Capo S, Oliviero S. Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J Mol Biol 2001; 306:985-96; PMID:11237613; http://dx.doi.org/10.1006/jmbi.2000.4335
17. Evellin S, Galvagni F, Zippo A, Neri F, Orlandini M, Incarnato D, et al. FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of αv and β3 integrin transcription. Mol Cell Biol 2013; 33:1198-209; PMID:23319049; http://dx.doi.org/10.1128/MCB.01054-12
18. Salameh A, Galvagni F, Anselmi F, De Clemente C, Orlandini M, Oliviero S. Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL. J Biol Chem 2010; 285:23096-104; PMID:20507983; http://dx.doi.org/10.1074/jbc.M109.087221
19. Schreiber M, Wang ZQ, Jochum W, Fetka I, Elliott C, Wagner EF. Placental vascularisation requires the AP-1 component fra1. Development 2000; 127:4937-48; PMID:11044407
20. Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 2009; 15:392-400; PMID:19305413; http://dx.doi.org/10.1038/nm.1941
21. Chamboredon S, Briggs J, Vial E, Hurault J, Galvagni F, Oliviero S, et al. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3. Oncogene 2003; 22:4047-61; PMID:12821939; http://dx.doi.org/10.1038/sj.onc.1206713
22. Estreicher A, Mühlhauser J, Carpentier JL, Orci L, Vassalli JD. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 1990; 111:783-92; PMID:2166055; http://dx.doi.org/10.1083/jcb.111.2.783
23. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010; 11:23-36; PMID:20027185; http://dx.doi.org/10.1038/nrm2821
24. Alexander RA, Prager GW, Mihaly-Bison J, Uhrin P, Sunzenauer S, Binder BR, et al. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. Cardiovasc Res 2012; 94:125-35; PMID:22287577; http://dx.doi.org/10.1093/cvr/cvs017
25. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994; 269:32380-8; PMID:7528215
26. Wei C, Möller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14:55-63; PMID:18084301; http://dx.doi.org/10.1038/nm1696
27. Mata-Greenwood E, Liao WX, Wang W, Zheng J, Chen DB. Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric-oxide synthase expression in placental artery endothelial cells. J Biol Chem 2010; 285:17348-58; PMID:20371606; http://dx.doi.org/10.1074/jbc.M109.092791